comprehensive -WSS

comprehensive

author：fashion 2025-09-29 15:24:33 - browse：1

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： FDA approves potent Eli Lilly obesity drug, Zepbound

WSS

UCSF medical school apologizes for unethical prisoner experiments

Diversify hospital leadership teams to protect BIPOC patient health

People with mental disorders often marry others with same

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Young boy dies in trial for Pfizer Duchenne gene therapy

Insurer loopholes limit power of law against surprise medical bills

Wikipedia

comprehensive

leisure time

Alkermes shareholders re

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

How to save PrEP access — and even expand it

Senate panel clears PBM, hopsital reforms

Bright Health sells Medicare Advantage business to Molina

Removing probiotics from the NICU could threaten preemies' health

In Memoriam: Notable people who died in 2023

The new shift in health care is toward less care

Moonlake's readout produced a cash windfall. Risks remain

U.K. decision on ALS drug has neurologists, advocates up in arms

explore

Study: New antibiotic targets gonorrhea as well as last existing drug

Sanofi CEO defends move to abandon profit guidance, boost research

Overprescribed: High cost isn't America's only drug problem

Scientific mystery highlights the blind spots in genomics databases

10 million people disenrolled from Medicaid over past six months

Will General Catalyst be the first of many hospital takeovers?

focus

Wikipedia

hotspot

hotspot